A Study Investigating Drivers of Physician and Patient Satisfaction Towards Treatment
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 261
- 试验地点
- 1
- 主要终点
- Number and Percentage of Patients by Patient-reported Level of Satisfaction With Current MS Treatment
研究概览
简要总结
The aim of this study is to assess physician and patient satisfaction with ofatumumab using data collected from physicians and their multiple sclerosis (MS) patients in real-world clinical practice across the United Kingdom (UK), France, Germany, Italy, Spain, China, Japan, and Brazil.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Physician inclusion criteria:
- •Physicians must be actively involved in the treatment/management of patients with MS
- •Consult with a minimum of 16 MS patients (>5 in Japan and China, >10 in Brazil) per month
- •Patient inclusion criteria:
- •Patients for whom physicians complete a Physician Completed Patient Record Form (PRF), and therefore are included in the pool of data for analysis, are based on the following criteria:
- •Patients who had a physician-made diagnosis of MS before or at the time of data collection
- •Patients must not currently be involved in a clinical trial
- •Patients ≥18 years old
- •For patients included in the ofatumumab sample, they must have been receiving ofatumumab for >12 months at the time of data collection
排除标准
- 未提供
研究组 & 干预措施
MS Patient Cohort
Adult patients diagnosed with relapsing multiple sclerosis (RMS) who are receiving treatment with ofatumumab, and who are invited to participate following a consult with their physician.
结局指标
主要结局
Number and Percentage of Patients by Patient-reported Level of Satisfaction With Current MS Treatment
时间窗: 1 Day
Patient's level of satisfaction with current treatment categorized as follows: * Completely dissatisfied * Moderately dissatisfied * Neither dissatisfied nor satisfied * Moderately satisfied * Completely satisfied * Not on any current treatment for MS
Number and Percentage of Patients by Patient-reported MS Status With Their Current Medication Compared to Previous Medication
时间窗: 1 Day
MS status, as reported by the patient, categorized as follows: * Very much better * Much better * A little better * No change * A little worse * Much worse * Very much worse * Don't know * No previous medication taken for MS
Number and Percentage of Patients by Physician-reported Patient Response to Current MS Treatment
时间窗: 1 Day
How well the patient is responding to current treatment rated by the physician from 1 (very poorly) to 5 (very well).
Number and Percentage of Patients by Physician-reported Level of Satisfaction With the Patient's Current MS Treatment
时间窗: 1 Day
Physician's level of satisfaction with patient's current treatment categorized as follows: * Completely dissatisfied * Moderately dissatisfied * Neither dissatisfied nor satisfied * Moderately satisfied * Satisfied * Completely satisfied
Number and Percentage of Patients Adherent to Current MS Treatment as Reported by the Physician
时间窗: 1 Day
Adherence, as reported by the physician, categorized as follows: * Completely adherent * Mostly adherent * Somewhat adherent * A little adherent * Not at all adherent * Too early in patient's regimen to tell * Don't know
Number and Percentage of Patients by Physician-reported Change in Patient Condition Since Initiation of Current MS Treatment
时间窗: 1 Day
Change in condition, as reported by the physician, categorized as follows: * Very much improved * Much improved * A little bit improved * No change * A little bit worse * Much worse * Very much worse
次要结局
- Number and Percentage of Patients by Factors That Influence How the Patient Rates Current Medication Compared to Previous Medication(1 Day)
- Number and Percentage of Patients by Physician-reported Reason for Current MS Treatment Choice(1 Day)
- Number and Percentage of Patients by Physician-reported Top 5 Reasons for Current MS Treatment Choice(1 Day)
- Number and Percentage of Patients by Physician-reported Main Areas of Improvement for the Patient's Current MS Treatment(1 Day)